Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial

  • Mohamed Mahmoud Hassan
  • Emad Gerges Saleh
  • Norma Osama Abdalla
  • Noha Hassan Radwan
  • Ekramy Mansour Abdelghfar
Keywords: Lidocaine, Dexmedetomidine, Interleukins, Tumor necrosis factor-α, Stress response, Pelvi–abdominal cancer, Surgery

Abstract

Background & Objectives: Stress response to extensive surgeries in cancer patients results in an imbalance between the pro-inflammatory and anti-inflammatory cytokines, besides activating an inflammatory cascade. We investigated the comparative effects of intravenous infusion of dexmedetomidine and lidocaine on proinflammatory cytokines and the stress reaction.

Methodology: A prospective randomized double blind trial was performed in National Cancer Institute. 54 patients scheduled for pelvi–abdominal cancer surgery under general anesthesia were randomly allocated to three equal groups. Lidocaine group: patients received 1.5 mg/kg loading dose of lidocaine followed by 1.5 mg/kg/h infusion; Dexmedetomidine group: received a loading dose of dexmedetomidine 1 µg/kg followed by infusion of 0.5 µg/kg/h; or Saline group: received 50 ml of normal saline followed by infusion at a rate of 10 ml/h till the end of the surgery. The primary outcome was a postoperative target level of IL–6 after 24 h.

Results: Immediate and 24 h postoperative IL–6 and TNFα were significantly lower in both dexmedetomidine and lidocaine groups compared to the control group (P < 0.001). Dexmedetomidine group had a significantly lower IL–6 and TNFα levels compared to lidocaine group at immediate postoperative and 24 h postoperative period (P < 0.001). Dexmedetomidine and lidocaine groups had a significantly lower lactate and insulin levels compared to the control group immediately postoperatively as well as 24 h postoperatively (P < 0.001). The dexmedetomidine group had a significantly lower lactate levels compared to the lidocaine group immediately postoperatively only. The lidocaine group had lower insulin level than the control group regarding immediate postoperative period only.

Conclusion: Intraoperative infusion of dexmedetomidine or lidocaine, both attenuate the postoperative levels of proinflammatory cytokines and stress response in patients undergoing pelvi–abdominal cancer surgeries.

Clinical trial registration: The study was registered at clinicaltrials.gov (NCT 04148599).

Key words: Lidocaine; Dexmedetomidine; Interleukins; Tumor necrosis factor-α; Stress response; Pelvi–abdominal cancer; Surgery

Abbreviations: TNF - Tumor necrosis factor; IL – Interleukins;

Citation: Hassan MM, Saleh RG, Abdalla NO, Radwan NH, Abdelghfar EM. Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial. Anaesth. pain intensive care 2021;26 (1):44-52.

DOI: 10.35975/apic.v26i1.1765

Received: February 15, 2021, Reviewed: December 02, 2021, Accepted: December 05, 2021

Author Biographies

Mohamed Mahmoud Hassan

Lecturer, Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.

Emad Gerges Saleh

Professor, Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.

Norma Osama Abdalla

Assistant Lecturer, Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.

Noha Hassan Radwan

Lecturer, Department of Clinical Pathology and Oncological Laboratory Medicine, National Cancer Institute, Cairo, Egypt.

Ekramy Mansour Abdelghfar

Lecturer, Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.

Published
02-07-2022
How to Cite
Hassan, M., Saleh, E., Abdalla, N., Radwan, N., & Abdelghfar, E. (2022). Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi–abdominal cancer surgeries: a randomized clinical trial. Anaesthesia, Pain & Intensive Care, 26(1), 44-52. https://doi.org/10.35975/apic.v26i1.1765
Section
ORIGINAL RESEARCH